Alshymaa A Hassnine (Alshymaa Hassnine)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Long Non Coding Rna

Transforming Growth Factor

Peritoneal Dialysis

Prognostic Factors

Top Venues

BMJ open gastroenterology

Canadian journal of gastroenterology & hepatology

Pharmacogenomics and personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Alshymaa A Hassnine, Amr M Elsayed
COVID-19 in Cirrhotic Patients: Is Portal Vein Thrombosis a Potential Complication? Canadian journal of gastroenterology & hepatology 2022 (2022)
Mona A Abu El-Makarem, Mariana F Kamel, Ahmed A Mohamed, Hisham A Ali, Mahmoud R Mohamed, Alaa El-Deen M Mohamed, Ahmed M El-Said, Mahmoud G Ameen, Alshymaa A Hassnine, Hatem A Hassan
Down-regulation of hepatic expression of GHR/STAT5/IGF-1 signaling pathway fosters development and aggressiveness of HCV-related hepatocellular carcinoma: Crosstalk with Snail-1 and type 2 transforming growth factor-beta receptor. PloS one 17 (11) (2022)
Amal A Mohamed, Alshymaa A Hassnine, Amr Elsayed, Mahmoud Montaser, Yasmeen Ismail, Ahmed El-Demery, Eman Sultan, Rania S Abdel Aziz, Eman Eldemiry, Radwa Hagag, Amal A El Kholy, Eman Salah
Isotretinoin Induced Hyperlipidemia and Impact of Leptin Gene rs 7799039 Polymorphism in Safety of Acne Patients. Pharmacogenomics and personalized medicine 14 (2021)
Amr Elsayed, Ehab M Abdelraheem, Hatem Hassan, Abbas Abbas, Alshymaa A Hassnine
Efficacy of antiviral therapy in patients with post-hepatitis C liver cirrhosis: is hyperuricaemia a potential adverse effect? BMJ open gastroenterology 7 (1) (2021)